DAPAGLIFLOZIN VERSUS A DIPEPTIDYL PEPTIDASE 4 INHIBITOR (DPP4) BOTH ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): IMPACT ON HEALTH, QUALITY OF LIFE AND COSTS IN THE TURKISH CLINICAL SETTING

Thumbnail
View/Open
Date
2015
Author
Malhan, S.
Guler, S.
Yetkin, I.
Ignacio, T.J.
Verheggen, B.
Charokopou, M.
xmlui.mirage2.itemSummaryView.MetaData
Show full item record
URI
https://www.valueinhealthjournal.com/article/S1098-3015(15)04172-8/pdf
http://hdl.handle.net/11727/4055
xmlui.mirage2.itemSummaryView.Collections